InveniAI retweeted
Happening at #BIO2022: James A. Geraghty joined Paul Hastings of @nkartatx to discuss Geraghty’s new book, which explores the origin of the Orphan Drug Act and the impact nearly 40 years later. nuvi.me/8327rb
InveniAI retweeted
InveniAI and Kyowa Kirin Announce Achievement of Milestone in Research Collaboration inveniai.com/press-detail.ph… @Inveni_AI @KyowaKirin_US More Life Science Business News at [LSUS] at life-sciences-usa.com/news/v…
InveniAI retweeted
InveniAI marks milestone in partnership with Japanese firm / ow.ly/9rBt50JnqlM @Inveni_AI
InveniAI retweeted
Erin Andrews and Venus Williams have overcome obstacles in their paths to be true success stories and inspirations to millions. Thank you for a great discussion this morning on careers, success, and prioritizing health. #BIO2022
InveniAI retweeted
Good Day BIO Live from San Diego – Wednesday, June 15, 2022 teapaw.org/i/broadcasts/1YqGopQLR…
InveniAI retweeted
Hear an in-depth discussion on the importance of the Prescription Drug User Fee Act (PDUFA) VII and potential new policies needed to provide a pathway for innovative new treatment. Sponsored by @TravereRare. #BIO2022 #SuperSession nuvi.me/1p33bc
InveniAI retweeted
May is #MentalHealthAwarenessMonth and at #BTAI, we are raising awareness to help fight the stigma, provide support and educate the public on mental health illnesses.
InveniAI retweeted
UPDATE: We are proud to announce, along with @BioNTech_Group, that our mRNA-based #vaccine candidate has, at an interim analysis, demonstrated initial evidence of efficacy against #COVID19 in participants without prior evidence of SARS-CoV-2 infection.
InveniAI retweeted
Congratulations to CT company @Inveni_AI on their new collaboration with @GSK #WWFHCT @NewHavenBiz newhavenbiz.com/article/glax…
InveniAI retweeted
Replying to @biotechnation
@biotechnation will lead the discussion Wednesday in session created by @Inveni_AI and @russopartners #BIODigital #AI @IAmBiotech biodigital.hubb.me/schedule-… – at Lakes by the Bay, FL
InveniAI retweeted
More than 1/3 patients in Phase 3 SERENITY trials have been enrolled & treated. To date, #BTAI has not observed a change resulting from COVID-19 pandemic & maintains previous guidance that SERENITY I & II are expected to be completed by mid-year 2020.
bioxceltherapeutics.com/news…
InveniAI retweeted
@BioXcel_Tx Announces 1st Patient Enrollment in Phase 1b/2 study of #BXCL501 for Acute Treatment of Agitation Associated with Dementia.
ir.bioxceltherapeutics.com/p…
InveniAI retweeted
Does your product portfolio include #AI solutions that can help the #healthcare industry? This conversation between James Maguire of our Datamation site and Dr. Krishnan Nandabalan, founder and CEO of @Inveni_AI, is a must watch. hubs.ly/H0lM3kK0
InveniAI retweeted
$INVEN InveniAI Corporation helping to facilitate drug discovery with its AI-driven technology tinyurl.com/y45zyphf via @proactive_UK @Inveni_AI #INVEN #brighterir #AndrewScottTV
InveniAI retweeted
Our sister company @inveni_AI took a seat on @iambiotech's #BIF2019 panel discussing #AI in drug development. CEO and founder Krishnan Nandabalan's #AI & #ML platform is transforming #innovation. #awardwinning #inveniai #sanfrancisco
InveniAI retweeted
InveniAI Launches Suite of Products Powered by AlphaMeld™, an Artificial Intelligence Platform, to Enable Robust Decision Making for Multiple Stakeholders in the Life Sciences inveniai.com/inveniai-launch…
InveniAI retweeted
Krishnan Nandabalan of @Inveni_AI discusses the proliferation of data in the life sciences, how his company’s artificial intelligence platform is being used by life sciences companies, and what he expects the ultimate payoff from this technology will be. soundcloud.com/levine-media-…
InveniAI retweeted
InveniAI Appoints Industry Veteran Dr. Amit Agrawal to Board of Directors and Expands its Operations into the EU - inveniai.com/microsoft-featu…
InveniAI retweeted
Merging AI, machine learning, and biotech, we have @Inveni_AI CEO Krishnan Nandabalan here to tell us about the latest applications of their AI and ML platform #BIO2019


![[iito] Life Science (@iitoLifeScience) profile picture](https://pbs.twimg.com/profile_images/555518370523525120/54L7-_yi_400x400.jpeg)
![Image from [iito] Life Science (@iitoLifeScience)](https://pbs.twimg.com/media/FUJh0wVXsAIHWxs.jpg?name=small&format=webp)


















